Next Article in Journal
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma
Previous Article in Journal
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve

1
Department of Obstetrics and Gynecology, Faculty of Medicine, Nigde Omer Halisdemir University, 51240 Nigde, Turkey
2
School of Health Sciences, Cappadocia University, 50400 Nevsehir, Turkey
3
Op. Dr. Erol Karakas Gynecology-Obstetrics-Genital Aesthetics and Sexual Health Clinic, 38140 Kayseri, Turkey
4
Department of Histology and Embryology, Faculty of Medicine, Erciyes University, 38030 Kayseri, Turkey
5
Hakan Cetinsaya Good Clinical Practice and Research Center, 38030 Kayseri, Turkey
6
Obsterics annd Gynecology Clinic, Nigde Omer Halisdemir University Training and Research Hospital, 51100 Nigde, Turkey
7
Obstetrics and Gynecology Clinic, Aksaray Training and Research Hospital, 68200 Aksaray, Turkey
8
Deparment of Clinical Microbiology and Infectious Disease, Faculty of Medicine, Erciyes University, 38030 Kayseri, Turkey
*
Author to whom correspondence should be addressed.
Vaccines 2025, 13(4), 345; https://doi.org/10.3390/vaccines13040345
Submission received: 30 January 2025 / Revised: 8 March 2025 / Accepted: 21 March 2025 / Published: 24 March 2025
Editorial Note: Due to an editorial processing error, this article was incorrectly included within the Special Issue COVID Vaccines: Design, Development, and Immune Response Studies: 2nd Edition upon publication. This article was removed from this Special Issue’s webpage on 17 March 2026 but remains within the regular issue in which it was originally published. The editorial office confirms that this article adhered to MDPI's standard editorial process (https://www.mdpi.com/editorial_process).

Abstract

Objectives: This study aimed to elucidate the effects of messenger RNA (mRNA) and inactivated coronavirus disease 2019 (COVID-19) vaccines on ovarian histology and reserve in rats. Methods: Thirty female Wistar albino rats, aged 16–24 weeks, were randomly divided into three groups (n = 10): control, mRNA vaccine, and inactivated vaccine groups. Each vaccine group received two doses (on day 0 and day 28) at human-equivalent doses. Four weeks post-second vaccination, ovarian tissues were harvested for analysis. Results: Immunohistochemical analysis was performed to evaluate the expression of transforming growth factor beta-1 (TGF-β1), vascular endothelial growth factor (VEGF), caspase-3, and anti-Müllerian hormone (AMH) in ovarian follicles. Both vaccines induced significant increases in TGF-β1, VEGF, and caspase-3 expression, with more pronounced effects in the mRNA vaccine group. Conversely, AMH expression in the granulosa cells of primary, secondary, and antral follicles showed marked reductions (p < 0.001). The counts of primordial, primary, and secondary follicles decreased significantly in the inactivated vaccine group relative to controls and further in the mRNA vaccine group compared to the inactivated group (p < 0.001). Additionally, the mRNA vaccine group exhibited a decrease in antral and preovulatory follicles and an increase in atretic follicles compared to the other groups (p < 0.05). The serum AMH level was diminished with the mRNA vaccination in comparison with the control and inactivated groups. Conclusions: Our findings suggest that both mRNA and inactivated COVID-19 vaccines may detrimentally impact ovarian reserve in rats, primarily through accelerated follicular loss and alterations in apoptotic pathways during folliculogenesis. Given these observations in a rat model, further investigations into the vaccines’ effects on human ovarian reserve are needed.
Keywords: rat; mRNA vaccine; inactivated COVID-19 vaccines; ovarian reserve; follicular atresia rat; mRNA vaccine; inactivated COVID-19 vaccines; ovarian reserve; follicular atresia

Share and Cite

MDPI and ACS Style

Karaman, E.; Yavuz, A.; Karakas, E.; Balcioglu, E.; Karaca, B.; Doganay, H.N.; Sacinti, K.G.; Yildiz, O. Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve. Vaccines 2025, 13, 345. https://doi.org/10.3390/vaccines13040345

AMA Style

Karaman E, Yavuz A, Karakas E, Balcioglu E, Karaca B, Doganay HN, Sacinti KG, Yildiz O. Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve. Vaccines. 2025; 13(4):345. https://doi.org/10.3390/vaccines13040345

Chicago/Turabian Style

Karaman, Enes, Adem Yavuz, Erol Karakas, Esra Balcioglu, Busra Karaca, Hande Nur Doganay, Koray Gorkem Sacinti, and Orhan Yildiz. 2025. "Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve" Vaccines 13, no. 4: 345. https://doi.org/10.3390/vaccines13040345

APA Style

Karaman, E., Yavuz, A., Karakas, E., Balcioglu, E., Karaca, B., Doganay, H. N., Sacinti, K. G., & Yildiz, O. (2025). Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve. Vaccines, 13(4), 345. https://doi.org/10.3390/vaccines13040345

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop